Summary
Historically, Sir Isaac Newton, with a great perspective of geometry, analysed an elliptical orbit derived from Kepler’s primary astronomical data analysis, and the sir elicited the theory of gravitation. Namely, secondary analysis with geometry was an essential step in physics. Then, with a geometrical perspective, a re-analysis of a chart in the figure is also practical in biomedicine? Nowadays, some image-checking AI detects research misconduct but not for useful, latent findings1. Taking our concept one step further, we focused on a geometrical meaning of the confidence interval error bar. As an exploratory data analysis know-how in a figure of meta-regression analysis, we conceived a method based on recognising geometrical patterns (layered hyperbolic shapes) suspected of overlapping subgroups. Here we show the result that we applied our ideas to the traveller’s thrombosis (economy class syndrome) and coronavirus disease 2019 (COVID-19), both of which were suspected of having overlooked information from many controversy2–21. Our analysis implied two S-curve types of risk increasing during a flight in the traveller’s thrombosis. Also, our analysis demonstrated overlooked cyclic patterns on the onset of thrombosis. This result suggests a strong relationship between travel and starting oral contraceptives (e.g., honeymoon and starting birth control oral contraceptives), which means that risk diversification might allow more safe use of oral contraceptives. In the COVID-19, our analysis demonstrated unrecognised scatter plot patterns on cardiac biomarkers, which may serve studies for pathophysiology in COVID-19 patients. Regarding the above findings, pattern recognition of hyperbolic shapes can contribute to a significant discovery in data mining.
Competing Interest Statement
Keiichiro Kimoto has been in charge of external advisor for Data Strategy Research Institute but reserved no financial support for this study. Except for this, the authors have no conflicts of interest and have no financial disclosures that should be disclosed.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ONLY openly available two types of human data. Firstly, this study performed meta-analyses as secondary analysis. The source of the data was described in the method section. Secondary, this study analyzed measured values from figures in previous published scientific papers. All the figures were appropriately treated with careful attention to the copyright issues to protect the integrity of the science. The sources of the original papers were described in the figure legend following the copyright holder's instructions. This study suggests a new method for exploratory data analysis and reports some epidemiological findings during the evaluation process. So, there were no applicable guidelines. However, this study carefully follows the usage of the statistical analysis method and the whole process was precisely described in the method section and Extended Fig. 1.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data availability statement. We analyzed clinical data published by other studies (third parties). Used data is identified by indicated information of citation (reference numbers and list of references). The corresponding author responds to inquiries in the case of measured values from published figures requested by reviewers or readers. Code availability statement. Correspondence author (KK) can respond to inquiries for the corresponding author's email address on offering the Python source code and spreadsheet software files for statistical analysis.